Concepedia

Publication | Closed Access

LONG-TERM EFFECT OF ANTIANGIOGENIC THERAPY FOR RETINOPATHY OF PREMATURITY Up to 5 Years of Follow-up

DOI

116

Citations

48

References

2012

Year

María Ana Martinez-Castellanos, Shulamit Schwartz, Myriam Lucía Hernández-Rojas, Veronica Konjara, Gerardo García‐Aguirre, José Luis Guerrero-Naranjo, R.V. Paul Chan, Hugo Quiroz–Mercado
Retina

Abstract

Five years of follow-up in a small series suggest that intravitreal bevacizumab for retinopathy of prematurity results in apparently preserved ocular function and systemic development.

References

YearCitations

Page 1